Gilead Sciences's office in Ireland: North Dock Two North Wall Quay Dublin D VY Ireland

Business Address: North Dock Two 93-94 North Wall Quay Dublin 1 D01 V8Y6 Ireland

Phone: +35315068400

E-mail: ie.customerservice@gilead.com

Web: https://www.gilead.com

Type Public
Traded as
  • Nasdaq: GILD
  • NASDAQ Biotechnology Component
  • NASDAQ-100 Component
  • S&P 100 Component
  • S&P 500 Component
Industry
  • Pharmaceutics
  • Biotechnology
Founded June 22, 1987 (1987-06-22)
Headquarters Foster City, California, United States
Area served Worldwide
Key people
  • Daniel O'Day
    (CEO and Chairman)
  • Andrew Dickinson
    (CFO)
  • Tomáš Cihlář
    (Vice president, and
    Senior Director, Biology)
Products
  • AmBisome
  • Atripla
  • Biktarvy
  • Complera
  • Cayston
  • Descovy
  • Emtriva
  • Epclusa
  • Genvoya
  • Harvoni
  • Hepsera
  • Letairis
  • Lexiscan
  • Macugen
  • Odefsey
  • Ranexa
  • Sovaldi
  • Stribild
  • Tamiflu
  • Truvada
  • Tybost
  • Veklury
  • Vemlidy
  • Viread
  • Vosevi
  • Yescarta
  • Zydelig
Revenue Increase US$27.31 billion (2021)
Operating income Increase US$9.92 billion (2021)
Net income Increase US$6.23 billion (2021)
Total assets Decrease US$67.95 billion (2021)
Total equity Increase US$21.06 billion (2021)
Number of employees Increase 14,400 (2021)

At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases. Through bold and transformative science, we’re creating possibilities that have the potential to become the next generation of life-changing medicines. Our ambition is evident in our mission. Because the impossible is not impossible. It’s what’s next.

Other Gilead Sciences's locations in Ireland

Gilead Sciences's locations around the world

Subscribe